找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Human Monoclonal Antibodies; Methods and Protocol Michael Steinitz Book 2019Latest edition Springer Science+Business Media, LLC, part of Sp

[復制鏈接]
樓主: BULK
31#
發(fā)表于 2025-3-27 00:50:57 | 只看該作者
32#
發(fā)表于 2025-3-27 03:13:24 | 只看該作者
33#
發(fā)表于 2025-3-27 08:35:22 | 只看該作者
Methods in Molecular Biologyhttp://image.papertrans.cn/h/image/429320.jpg
34#
發(fā)表于 2025-3-27 10:11:54 | 只看該作者
35#
發(fā)表于 2025-3-27 16:15:05 | 只看該作者
Springer Science+Business Media, LLC, part of Springer Nature 2019
36#
發(fā)表于 2025-3-27 19:32:13 | 只看該作者
Human Monoclonal Antibodies978-1-4939-8958-4Series ISSN 1064-3745 Series E-ISSN 1940-6029
37#
發(fā)表于 2025-3-28 00:01:43 | 只看該作者
Book 2019Latest editiond tips on troubleshooting and avoiding known pitfalls..Uniqueand thorough, .Human Monoclonal Antibodies: Methods and Protocols, Second Edition. is a valuable tool for novice and expert researchers interested in learning more about this evolving field..
38#
發(fā)表于 2025-3-28 05:12:31 | 只看該作者
Human Monoclonal Antibodies: The Benefits of Humanization,aminating protein aggregates, or “aggregates” arising from antibodies complexing with their antigen. I here summarize our efforts to engineer antibodies to harness optimal effector functions, while also minimizing their immunogenicity. Potential avenues to achieve the latte are predicted from classi
39#
發(fā)表于 2025-3-28 09:31:18 | 只看該作者
IgM Natural Autoantibodies in Physiology and the Treatment of Disease,different disease conditions such as atherosclerosis, cancer, and autoimmune disease. We also describe the discovery of two reparative IgM-NAAs by our laboratory and delineate their proposed mechanisms of action in central nervous system (CNS) disease.
40#
發(fā)表于 2025-3-28 12:42:43 | 只看該作者
Monoclonal Antibodies for the Treatment of Melanoma: Present and Future Strategies,nse rates, low relapse rates and showed manageable safety profile. Antibodies against ligands for PD-1 receptors were then developed to overcome the adverse effects of anti-PD-1 antibodies and combination of monoclonal antibodies (ipilimumab plus nivolumab) was tested to increase the response rates.
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 11:35
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
益阳市| 保定市| 肃宁县| 北海市| 安顺市| 靖江市| 曲沃县| 新平| 枝江市| 余姚市| 定远县| 新绛县| 天峻县| 平安县| 清涧县| 禹州市| 长白| 大竹县| 逊克县| 元朗区| 砚山县| 南充市| 安图县| 珲春市| 庆城县| 南丹县| 叶城县| 五莲县| 确山县| 榆林市| 七台河市| 陇西县| 措美县| 丰宁| 泰安市| 垫江县| 密云县| 南汇区| 金湖县| 万年县| 靖西县|